CreditReports.dk
HomeScreen companies

FORWARD PHARMA A/S Financials, key figures and credit report

CVR number: 28865880 Established 2005 Industry: 72 Scientific research and development
Company contact details
Strandvejen 125, 2900 Hellerup investors@forward-pharma.com www.forward-pharma.com
Gross profit 133.0 kDKK FY 2016 -24.9% vs 2015
EBIT -40 308.0 kDKK FY 2016 -72.9% vs 2015
Net debt -52 636.0 kDKK FY 2016 -18.5% vs 2015
Quick ratio 6.0 FY 2016 -21.2 vs 2015

Company information

Official name
FORWARD PHARMA A/S
Personnel
2 persons
Established
2005
Company form
Limited company
Industry

Data sources and methodology

The information about FORWARD PHARMA A/S combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2016.

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About FORWARD PHARMA A/S

FORWARD PHARMA A/S (CVR number: 2886588-0) is a company from KØBENHAVN. The company recorded a gross profit of 133 kDKK in 2016. The operating profit was -40.3 mDKK, while net earnings were 2032 kDKK. The profitability of the company measured by Return on Assets (ROA) was -4.9 %, which can be considered poor but Return on Equity (ROE) was 1.1 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 95.2 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. FORWARD PHARMA A/S's liquidity measured by quick ratio was 6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2013
2014
2015
2016
Volume
Net sales
Gross profit151.00143.00177.00133.00
EBIT-2 576.00-9 849.00-23 310.00-40 308.00
Net earnings-9 225.00-13 662.00-51 065.002 032.00
Shareholders equity total-14 322.00238 017.00176 695.00189 657.00
Balance sheet total (assets)15 061.00240 310.00179 933.00199 203.00
Net debt-44 407.00-52 636.00
Profitability
EBIT-%
ROA-8.7 %-6.4 %-24.4 %-4.9 %
ROE-61.3 %-10.8 %-24.6 %1.1 %
ROI-98.3 %-7.2 %-24.7 %-5.0 %
Economic value added (EVA)-2 549.47-8 999.04-34 560.02-37 445.85
Solvency
Equity ratio-48.7 %99.0 %98.2 %95.2 %
Gearing-18.2 %1.8 %
Relative net indebtedness %
Liquidity
Quick ratio0.140.327.26.0
Current ratio0.140.327.26.0
Cash and cash equivalents2 742.0044 043.0044 407.0056 060.00
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2016
-4.90%
Rating 15/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2016
95.2%
Rating 76/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of FORWARD PHARMA A/S before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Companies in the same industry

Page generated